Jiangsu Institute of Parasitic Diseases, Wuxi, Jiangsu Province, People's Republic of China.
Am J Trop Med Hyg. 2012 May;86(5):834-6. doi: 10.4269/ajtmh.2012.11-0701.
The purpose of the current study was to investigate the susceptibility of Schistosoma japonicum to praziquantel in low endemic foci of China. During the non-transmission period of schistosomiasis, a total of 43 of 1,242 subjects were identified as being infected with the parasite using parasitological stool examinations in two low-endemicity areas of China, with a prevalence rate of 3.46%. All stool-egg-positive subjects were treated with praziquantel in a single oral dose of 40 mg/kg or 30 mg/kg for two successive days. Six weeks post-treatment, no S. japonicum eggs were detected in the 43 treated villagers. The results indicate that the current efficacy of praziquantel against S. japonicum seems satisfactory and has not changed over the past three decades in the low endemic areas of China. It is also suggested that no evidence of tolerance or resistance to praziquantel in S. japonicum is detected in areas with low endemicity in China.
本研究旨在调查中国低流行区日本血吸虫对吡喹酮的敏感性。在血吸虫病非传播期间,采用寄生虫学粪便检查在我国两个低流行区共发现 1242 名受试者中有 43 名感染了寄生虫,感染率为 3.46%。所有粪便虫卵阳性者均采用吡喹酮单次口服 40mg/kg 或 30mg/kg 连续 2 天治疗。治疗后 6 周,43 名治疗村民的粪便中均未检测到日本血吸虫卵。结果表明,吡喹酮对日本血吸虫的当前疗效似乎令人满意,在过去 30 年中,中国低流行区没有变化。也表明在低流行地区未发现日本血吸虫对吡喹酮有耐受性或耐药性的证据。